
Nektar Therapeutics (NASDAQ:NKTR) Q4 2024 Earnings Call Transcript
Nektar Therapeutics (NASDAQ:NKTR) Q4 2024 Earnings Call Transcript March 12, 2025 Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.15 EPS, expectations were $-0.13. Operator: Good day, and thank you for standing by. Welcome to the …